Position paper on olfactory dysfunction: 2023
- PMID: 37454287
- DOI: 10.4193/Rhin22.483
Position paper on olfactory dysfunction: 2023
Abstract
Background: Since publication of the original Position Paper on Olfactory Dysfunction in 2017 (PPOD-17), the personal and societal burden of olfactory disorders has come sharply into focus through the lens of the COVID-19 pandemic. Clinicians, scientists and the public are now more aware of the importance of olfaction, and the impact of its dysfunction on quality of life, nutrition, social relationships and mental health. Accordingly, new basic, translational and clinical research has resulted in significant progress since the PPOD-17. In this updated document, we present and discuss currently available evidence for the diagnosis and management of olfactory dysfunction. Major updates to the current version include, amongst others: new recommendations on olfactory related terminology; new imaging recommendations; new sections on qualitative OD and COVID-19 OD; updated management section. Recommendations were agreed by all co-authors using a modified Delphi process.
Conclusions: We have provided an overview of current evidence and expert-agreed recommendations for the definition, investigation, and management of OD. As for our original Position Paper, we hope that this updated document will encourage clinicians and researchers to adopt a common language, and in so doing, increase the methodological quality, consistency, and generalisability of work in this field.
Similar articles
-
Position paper on olfactory dysfunction.Rhinol Suppl. 2017 Mar;54(26):1-30. doi: 10.4193/Rhino16.248. Rhinol Suppl. 2017. PMID: 29528615 Review.
-
[Diagnosis and Therapy of Olfactory Dysfunction - State of the ArtThe neglected sense-new evidence highlights the significance of the human sense of smell].Wien Med Wochenschr. 2022 Feb;172(1-2):8-13. doi: 10.1007/s10354-021-00895-x. Epub 2021 Dec 1. Wien Med Wochenschr. 2022. PMID: 34851470 Free PMC article. German.
-
Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.Am J Rhinol Allergy. 2022 Mar;36(2):253-260. doi: 10.1177/19458924211053118. Epub 2021 Oct 27. Am J Rhinol Allergy. 2022. PMID: 34704454
-
Position paper on olfactory dysfunction.Rhinology. 2016 Jan 31;56(1):1-30. doi: 10.4193/Rhino16.248. Rhinology. 2016. PMID: 28623665
-
Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance.Otolaryngol Head Neck Surg. 2020 Jul;163(1):12-15. doi: 10.1177/0194599820926464. Epub 2020 May 5. Otolaryngol Head Neck Surg. 2020. PMID: 32366160 Review.
Cited by
-
Development of a Southeast Asian version of the "Sniffin Sticks" odor identification test.Eur Arch Otorhinolaryngol. 2025 May;282(5):2399-2409. doi: 10.1007/s00405-025-09303-1. Epub 2025 Mar 14. Eur Arch Otorhinolaryngol. 2025. PMID: 40087168
-
Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia.Biomedicines. 2024 Sep 12;12(9):2085. doi: 10.3390/biomedicines12092085. Biomedicines. 2024. PMID: 39335598 Free PMC article. Review.
-
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A "Real-Life" Observational Study.J Pers Med. 2024 Sep 23;14(9):1014. doi: 10.3390/jpm14091014. J Pers Med. 2024. PMID: 39338268 Free PMC article.
-
Validity and reliability of the Questionnaire of Olfactory Disorders for Italian-speaking patients with olfactory dysfunction.Acta Otorhinolaryngol Ital. 2024 Feb;44(1):42-51. doi: 10.14639/0392-100X-N2736. Acta Otorhinolaryngol Ital. 2024. PMID: 38420720 Free PMC article.
-
Factors Associated With Persisting Olfactory Dysfunction After COVID-19.Clin Otolaryngol. 2025 Jan;50(1):53-61. doi: 10.1111/coa.14233. Epub 2024 Sep 21. Clin Otolaryngol. 2025. PMID: 39305184 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials